COL1A1 and Myocardial fibrosis: While a neutralizing antibody against IL-22 led to increased COL1-A1, COL3-A1, MMP9 expression, and intensified myocardial fibrosis in DCM mice, suggesting that IL-22 protects the myocardium by inhibiting myocardial fibrosis [88].